Funded Year:
2022
Awarded to:
Larry Reiter, PhD
Amount:
$150,000
Institution:
University of Tennessee Health Science Center
Researcher:
Larry Reiter, PhD
The purpose of this project is to develop a cellular assay specific to circadian rhythm defects identified by the Reiter laboratory. The eventual goal is to use this assay to screen for compounds that can normalize these circadian defects, potentially identifying drugs that would address developmental and metabolic changes that accompany circadian rhythm defects in Prader-Willi (PWS) and Schaaf-Yang (SYS) syndromes.
2022
Larry Reiter, PhD
$150,000
University of Tennessee Health Science Center
Larry Reiter, PhD
The Foundation for Prader-Willi Research (federal tax id 31-1763110) is a nonprofit corporation with federal tax exempt status as a public charity under section 501(c)(3).
The mission of FPWR is to eliminate the challenges of Prader-Willi syndrome through the advancement of research and therapeutic development.
Copyright © 2020. All Rights Reserved. Terms of Use. Privacy Policy. Copyright Infringement Policy. Disclosure Statement.